Skip to main content

Advertisement

SpringerLink
Log in

Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Developing countries have a younger population of CML patients than developed countries. Patterns of age at diagnosis and incidence by geography and gross national income (GNI) are not well understood. A population-based descriptive study was conducted using data from the International Agency for Research on Cancer’s population-based registry compilation. Geographical regions were classified according to the United Nations World Macro Regions and Components. Age-Standardized Incidence Rates (ASR) were adjusted to the World Standard Population. Poisson regression was used to assess age-specific interactions. 57.2 % were male among 33,690 diagnoses. Median age at diagnosis was lowest in Africa and Asia (47 years) and highest in Oceania (72 years). ASR was lowest in African males (0.61 per 100,000) and Asian females (0.55 per 100,000) and highest in Oceania males and females (1.78 and 0.96 per 100,000, respectively). A significant interaction (p < 0.0001) between age (<50 years and >50 years) and region exists; no significant differences were seen by region in the <50 age-group while significant differences by region exist in the >50 age group. Population-based estimates suggest that the median age at diagnosis and incidence varies by region. Geographic and income heterogeneity suggest an important effect of environment that warrants further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Sawyers C. Chronic myeloid leukemia. N Engl J Med. 1999;340(7):1330–40.

    Article  PubMed  CAS  Google Scholar 

  2. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, Vol. IX. Lyon, IARC: IARC Scientific Publications No. 160; 2007.

  3. Rohrbacher M, Hasford J. Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol. 2009;22:295–302.

    Article  PubMed  Google Scholar 

  4. Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim D-W, Kweon I-Y, O’Neil WM, Saikia TK, Wang J. Chronic myeloid leukemia in Asia. Int J Hematol. 2009;89:14–23.

    Article  PubMed  Google Scholar 

  5. Heyssel R, Brill AB, Woodbury LA, Nishimura ET, Ghose T, Hoshino T, Yamasaki M. Leukemia in Hiroshima atomic bomb survivors. Blood. 1960;15(3):313–31.

    PubMed  CAS  Google Scholar 

  6. Mendizabal AM, Garcia-Gonzalez P, Levine PH. Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries. Cancer Epidemiol. 2013;37(3):247–54.

    Article  PubMed  Google Scholar 

  7. Tekinturhan E, Audureau E, Tavolacci M-P, Garcia-Gonzalez P, Ladner J, Saba J. Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program. BMC Health Serv Res. 2013;13:304–13.

    Article  PubMed  PubMed Central  Google Scholar 

  8. United Nations World Macro Regions and Components. http://unstats.un.org/unsd/methods/m49/m49regin.htm.

  9. World Bank Gross National Income per Capita. http://data.worldbank.org/indicator/NY.GNP.PCAP.CD.

  10. Howlander N, Noone A, Krapcho M, Neyman N, Aminou R, Altekruse S, Kosary C, Ruhl J, Tatalovich Z, Cho H et al: SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations). In: National Cancer Institute. vol. Bethesda, MS, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, 2012.

  11. Anderson WF, Chatterjee N, Ershler W, Brawley O. Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology and end results database. Breast Cancer Res Treat. 2002;76(1):27–36.

    Article  PubMed  CAS  Google Scholar 

  12. Scott DW: Multivariate Density Estimation. Theory, Practice and Visualization. New York; 1992.

  13. Jones MC, Marron JS, Sheather SJ. A brief survey of bandwidth selection for density estimation. J Am Stat Assoc. 1996;91(433):401–7.

    Article  Google Scholar 

  14. Klein RJ, Schoenborn CA: Age Adjustment Using the 2000 Projected U.S. Population. Healthy People 2010 statistical notes: no 20. In. Hyattsville, Maryland: National Center for Health Statistics; 2001.

  15. Blair A, Fraumeni J, Mason T. Geographic patterns of leukemia in the United States. J Chronic Dis. 1980;33(4):251–60.

    Article  PubMed  CAS  Google Scholar 

  16. Blair A, White D. Death certificate study of leukemia among farmers from Wisconsin. J Natl Cancer Inst. 1981;66(6):1027–30.

    PubMed  CAS  Google Scholar 

  17. Bonner MR, Williams BA, Rusiecki JA, Blair A, Beane Freeman LE, Hoppin JA, Dosemeci M, Lubin J, Sandler DP, Alavanja MCR. Occupational exposure to terbufos and the incidence of cancer in the Agricultural Health Study. Cancer Causes Control. 2010;21:871–7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Van Maele-Fabry G, Duhayon S, Lison D. A systematic review of myeloid leukemias and occupational pesticide exposure. Cancer Causes Control. 2007;18:457–78.

    Article  PubMed  Google Scholar 

  19. Deininger MWN, Druker BJ. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev. 2003;55(3):401–23.

    Article  PubMed  CAS  Google Scholar 

  20. Malhotra P, Varma S. Chronic myeloid leukaemia in India. Lancet. 2007;370:1127.

    Article  PubMed  Google Scholar 

  21. Hehlmann R, Hochhaus A, Baccarani M. LeukemiaNet obotE: chronic myeloid leukaemia. Lancet. 2007;370:342–50.

    Article  PubMed  CAS  Google Scholar 

  22. Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol. 2002;19(3):141–50.

    Article  PubMed  Google Scholar 

  23. Wang J, Huang X, Wu D, Hu J, Liu T, Hu Y, Meng F, Chen X, Hou M, Li Y, et al. Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China. Zhonghua Xue Ye Xue Za Zhi. 2009;30(11):721–5.

    PubMed  Google Scholar 

  24. Aziz Z, Iqbal J, Akram M, Saeed S. Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country. Cancer. 2007;109(6):1138–45.

    Article  PubMed  CAS  Google Scholar 

  25. Usmani S, Yunus S, Jamal Y. Overview of chronic myeloid leukemia patients in Pakistan in the pre-imatanib era. Asian Pac J Cancer Prev. 2009;10(6):1039–40.

    PubMed  Google Scholar 

  26. Wang A-H, Wang Y-Y, Yao Y, Xu Z-Z, Zhou L, Wang L, Chen Y, Shen Z-X, Hu J, Li J-M. Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006. J Exp Clin Cancer Res. 2010; 29(20).

  27. India Council of Medical Research. National Cancer Registry Programme Consolidated Report of the Population Based Cancer Registries 1990–1996: Incidence and Distribution of Cancer. In. New Delhi: Indian Council of Medical Research; 2001

  28. Aguayo A, Garcia-Alvarez E, Cazares-Ordonez Y, Crespo-Solis E, Martinez-Banos D, Guadarrama-Beltran E, Cervera-Ceballos EE, Lopez-Karpovitch X. Chronic myeloid leukemia: a clinicoepidemiologic and therapeutic description of a single institution in Mexico City. Clin Leuk. 2008;2(4):261–6.

    Article  Google Scholar 

  29. Funke VA, Medeiro CR, Lima DH, Setubal DC, Bitencourt MA, Bonfim CM, Ruiz J, Neto JZ, Pasquini R. Therapy of chronic myeloid leukemia with imatinib mesylate in Brazil: a study of 98 cases. Revista Brasileira de Hematologia e Hemoterapia. 2005;27(3):159–65.

    Article  Google Scholar 

  30. Luke C, Nguyen A-M, To B, Seshadri R, Hughes T, Bardy P, Colbeck M, Buranyi-Trevarton D, McMellon M, Roder D. Myeloid leukaemia treatment and survival—the South Australian experience, 1977 to 2002. Asian Pac J Cancer Prev. 2006;7:227–33.

    PubMed  Google Scholar 

  31. Australian Institute of Health and Welfare (AIHW). ACIM (Australian Cancer Incidence and Mortality) Books. Canberra: AIHW; 2012.

    Google Scholar 

  32. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA

    Adam M. Mendizabal, Naji Younes & Paul H. Levine

  2. Emmes, Rockville, MD, USA

    Adam M. Mendizabal

  3. Department of Epidemiology, University of Nebraska Medical Center, 600 S 42nd St, Omaha, NE, 68198, USA

    Paul H. Levine

Authors
  1. Adam M. Mendizabal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naji Younes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul H. Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul H. Levine.

Ethics declarations

Conflict of interest

The authors note no conflicts of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mendizabal, A.M., Younes, N. & Levine, P.H. Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia. Int J Hematol 103, 70–78 (2016). https://doi.org/10.1007/s12185-015-1893-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-015-1893-y

Keywords

Search

Navigation